Kolexia
Ramel Sophie
Pneumologie
Fondation Ildys Site De Perharidy
Roscoff, France
64 Activités
120 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mucoviscidose Fibrose Pneumonie à Pneumocystis Infections de l'appareil respiratoire Maladies pulmonaires Infections à Pseudomonas Inflammation Pneumopathie infectieuse Incontinence urinaire

Industries

Vertex
10 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Physical activity promotion in French cystic fibrosis centers: capitalizing on experience.
Physiotherapy theory and practice   12 février 2024
MuControl: Performances and Safety of MuCopilot, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis
Essai Clinique (Vertex)   17 novembre 2023
HomeCareSIMEOX: Efficiency and Acceptability of SIMEOX® Used Autonomously at Home for Bronchial Clearance in Patients With Cystic Fibrosis: Prospective, Randomized Controlled Study
Essai Clinique (Physio-Assist)   15 novembre 2023
Prevalence and severity of functional urinary and anorectal disorders and their impact on quality of life in cystic fibrosis.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society   29 octobre 2023
ITHI: Assessment of the Safety and Feasibility of a High-intensity Interval Training Program in Adult CF Patients: a Randomized Bicentric Pilot Study
Essai Clinique (Fondation Ildys)   14 septembre 2023
RAMBO: Impact on Quality of Life With Pulmonary RehAbilitation After Pulmonary eMBOlism: RAMBO Study
Essai Clinique (CHU Brest)   28 juillet 2023
KAF-BIOTA: Monitoring of the Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor: Study of the Pulmonary and Gut Microbiota and Inflammation
Essai Clinique (CHU Bordeaux)   07 juillet 2023
P102 Clear illustration of improved survival in cystic fibrosis using the Kaplan-Meier method: the 50-year experience of Brittany, France
Abstracts of the 46th European Cystic Fibrosis Conference   01 juin 2023
P130 Exploring consequences of highly effective modulator therapy on patient’s health pathways and cares in cystic fibrosis centers and beyond by a nationwide research programme in France (HORIZON)
Abstracts of the 46th European Cystic Fibrosis Conference   01 juin 2023
P086 The French clinical research network in cystic fibrosis more than 10 years of positive experience in clinical research for patients
Abstracts of the 46th European Cystic Fibrosis Conference   01 juin 2023